GIMEMA multicenter pilot study: characteristics of enrolled patients
Characteristic . | Total . | At least 2 years of age through 17 years of age* . | At least 18 years of age through 70 years of age . |
---|---|---|---|
Patients, n | 95 | 44 | 51 |
Male/female | 34/61 | 21/23 | 13/38 |
Median age, y (range) | 20 (2-70) | 5.7 (2-17.9) | 35.1 (19.9-70) |
Median platelet count, × 109/L (range) | 9 (1-35†) | 8 (1-26) | 10 (1-35†) |
Bleeding score‡ | |||
0 | 4 | 0 | 4 |
1 | 42 | 29 | 13 |
2 | 21 | 13 | 8 |
3 | 1 | 0 | 1 |
4 | 0 | 0 | 0 |
Characteristic . | Total . | At least 2 years of age through 17 years of age* . | At least 18 years of age through 70 years of age . |
---|---|---|---|
Patients, n | 95 | 44 | 51 |
Male/female | 34/61 | 21/23 | 13/38 |
Median age, y (range) | 20 (2-70) | 5.7 (2-17.9) | 35.1 (19.9-70) |
Median platelet count, × 109/L (range) | 9 (1-35†) | 8 (1-26) | 10 (1-35†) |
Bleeding score‡ | |||
0 | 4 | 0 | 4 |
1 | 42 | 29 | 13 |
2 | 21 | 13 | 8 |
3 | 1 | 0 | 1 |
4 | 0 | 0 | 0 |
This age group was further divided at the 10-years-old mark: 34 patients were ≥ 2 but < 10 years old (16 males, 18 females); 10 patients were ≥ 10 but < 18 years old (5 males, 5 females).
There were 2 adult patients (ages 30 years and 39 years) with platelet counts of 32 × 109/L and 35 × 109/L, and bleeding scores of 2 and 3, respectively.
Bleeding score was available for 68 of 95 patients.